Valuation : Bayer AG

Market Cap 48.02B 55.67B 45.17B 41.15B 77.39B 5,283B 77.8B 534B 208B 2,688B 209B 204B 8,912B P/E 2026 *
21.8x
P/E 2027 * 15.9x
Enterprise Value 77.98B 90.4B 73.35B 66.82B 126B 8,579B 126B 867B 338B 4,364B 339B 332B 14,470B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.08%
1 day-1.00%
1 week-0.20%
Current month-0.20%
1 month+2.21%
3 months+39.20%
6 months+16.99%
Current year+32.33%
1 week 48
Extreme 48
49.21
1 month 47.05
Extreme 47.05
50.4
Current year 33.13
Extreme 33.13
53.76
1 year 25.87
Extreme 25.87
53.76
3 years 18.22
Extreme 18.222
53.76
5 years 18.22
Extreme 18.222
67.84
10 years 18.22
Extreme 18.222
123.12
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-0.20% - - 55.67B
+0.28%-5.97%+58.34%+108.22% 1,034B
+2.01%-0.71%+53.07%+68.99% 654B
+1.39%-2.18%+23.57%+75.43% 459B
-1.50%-7.04%+33.55%+33.94% 343B
+6.25%+2.04%+28.97%+46.57% 307B
-0.07%-4.12%+0.95%+11.79% 251B
+1.92%-0.93%+52.28%+70.67% 237B
+0.51%-4.52%-19.50%-54.83% 202B
+2.45%+0.77%+32.71%+95.59% 186B
Average +1.35%-2.88%+29.33%+50.71% 407.95B
Weighted average by Cap. +1.59%-3.31%+38.40%+66.45%

Financials

2026 *2027 *
Net sales 45.77B 53.06B 43.06B 39.23B 73.76B 5,036B 74.16B 509B 198B 2,562B 199B 195B 8,494B 47.01B 54.5B 44.22B 40.28B 75.75B 5,172B 76.16B 523B 203B 2,631B 205B 200B 8,724B
Net income 2.14B 2.48B 2.01B 1.83B 3.44B 235B 3.46B 23.76B 9.25B 120B 9.3B 9.1B 396B 2.94B 3.41B 2.77B 2.52B 4.74B 324B 4.77B 32.71B 12.73B 165B 12.8B 12.52B 546B
Net Debt 29.95B 34.73B 28.18B 25.67B 48.27B 3,296B 48.53B 333B 130B 1,676B 130B 128B 5,559B 26.83B 31.11B 25.24B 22.99B 43.24B 2,952B 43.47B 298B 116B 1,502B 117B 114B 4,979B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
28/08/26 49.00 -.--% 2,764
01/09/26 €48.77 -0.67% 2,969
31/08/26 €49.10 +0.20% 1,807
28/08/26 €49.00 0.00% 2,764
27/08/26 €49.00 0.00% 3,609
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.88EUR
Average target price
57.39EUR
Spread / Average Target
+17.41%

Quarterly revenue - Rate of surprise